Lam le, MD
Surgery · Dallas, TXNPI 1861698052
Payments from drug & device makers
What this record shows
This record is dominated by education: $133,750 of the $180,104 with a category attached, or 74.3%. Intuitive Surgical accounts for 99.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $90,960 and has fallen 80.8% since, to $17,493 in 2025. Among surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 295 payments — averaging $610.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$179K
- Davol Inc.$1K
- Conmed Corporation$97
- AbbVie$90
- TELA Bio, Inc.$19
- Johnson & Johnson$16
- plus $16 from 1 others
What the payments were for
- Speaking & faculty fees$23,00013%
- Travel & lodging$9,9956%
- Food & beverage$13,0417%
- Education$133,75074%
- Gifts$3180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 271 | $178,587 |
| Davol Inc. | 15 | $1,278 |
| Conmed Corporation | 2 | $97 |
| AbbVie(2 entities) | 4 | $90 |
| TELA Bio, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $16 |
| Covidien LP | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$163,373
- DA VINCI SP$10,157
- Phasix Mesh$148
How this compares
$180,104 in reported general payments places this provider in the 95th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methocarbamol | 17 | $88 |
| Tramadol Hcl | 13 | $27 |
Paid to pharmacies, not to this prescriber.
Other surgery in Dallas
- Sachin KukrejaDallas$640K
- Walton TaylorDallas$369K
- Steven LeedsDallas$193K
- Aaron HoffmanDallas$185K
- Bola AladegbamiDallas$91K
- Michael HarkinsTomball$2.7M
- Douglas StoddardAustin$1.4M
- Steven FassAustin$989K
- Vineet ChoudhryAustin$851K
- Andy HawthorneRound Rock$843K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.